Outset Medical, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Outset Medical, Inc. on August 28, 2026, covering events occurring on August 27, 2026. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC under the symbol "OM".
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance event and contains no financial performance data.
Material Changes
The material change reported is the departure of John Brottem from his role as General Counsel. Mr. Brottem's departure is effective September 11, 2026. The Company states that the departure is not due to any dispute or disagreement with the Company or its management.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on future operations, or specific risk factors beyond the standard disclosure of the officer's departure.
Key Facts for Investor Verification
- John Brottem is departing as General Counsel effective September 11, 2026.
- The departure is voluntary and not related to any dispute with the Company.
- The Company has not announced a replacement for the General Counsel role in this filing.
- No financial results or operational updates are included in this specific report.